Increased Reticulocytosis during Infancy Is Associated with Increased Hospitalizations in Sickle Cell Anemia Patients during the First Three Years of Life
暂无分享,去创建一个
A. Schechter | Y. T. Lee | Jeffery L. Miller | E. Wright | E. Meier | N. Luban | C. Byrnes
[1] R. Ware,et al. A Prospective Pilot Newborn Screening and Treatment Program for Sickle Cell Anemia in the Republic of Angola , 2012 .
[2] Scott T. Miller,et al. Hydroxycarbamide in very young children with sickle-cell anaemia: a multicentre, randomised, controlled trial (BABY HUG) , 2011, The Lancet.
[3] M. Viana,et al. High reticulocyte count is an independent risk factor for cerebrovascular disease in children with sickle cell anemia , 2011, Pediatric blood & cancer.
[4] Jeffery L. Miller,et al. Expression patterns of fetal hemoglobin in sickle cell erythrocytes are both patient‐ and treatment‐specific during childhood , 2011, Pediatric blood & cancer.
[5] E. Carrol,et al. Susceptibility to invasive bacterial infections in children with sickle cell disease , 2010, Pediatric blood & cancer.
[6] Stephen W. Hartley,et al. Genetic modifiers of the severity of sickle cell anemia identified through a genome‐wide association study , 2009, American journal of hematology.
[7] C. Quinn,et al. Improved survival of children and adolescents with sickle cell disease. , 2008, Blood.
[8] O. Platt,et al. Hydroxyurea for the treatment of sickle cell anemia. , 2008, The New England journal of medicine.
[9] C. Quinn,et al. Prediction of adverse outcomes in children with sickle cell anemia: a study of the Dallas Newborn Cohort. , 2008, Blood.
[10] C. Hillyer,et al. Transfusion in the patient with sickle cell disease: a critical review of the literature and transfusion guidelines. , 2007, Transfusion medicine reviews.
[11] A. Schechter,et al. Fetal hemoglobin silencing in humans. , 2006, Blood.
[12] Scott T. Miller,et al. Prediction of adverse outcomes in children with sickle cell disease. , 2000, The New England journal of medicine.
[13] Scott T. Miller,et al. Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography. , 1998, The New England journal of medicine.
[14] R. Hebbel,et al. CD36-positive stress reticulocytosis in sickle cell anemia. , 1996, The Journal of laboratory and clinical medicine.
[15] C. Pegelow,et al. Clinical events in the first decade in a cohort of infants with sickle cell disease. Cooperative Study of Sickle Cell Disease. , 1995, Blood.
[16] G. Bray,et al. Assessing clinical severity in children with sickle cell disease. Preliminary results from a cooperative study. , 1994, The American journal of pediatric hematology/oncology.
[17] S. Davies,et al. Bone marrow transplantation for sickle cell disease. , 1993, Archives of disease in childhood.
[18] A. Schechter,et al. Levels of fetal hemoglobin necessary for treatment of sickle cell disease. , 1988, The New England journal of medicine.
[19] E Vichinsky,et al. Prophylaxis with oral penicillin in children with sickle cell anemia. A randomized trial. , 1986, The New England journal of medicine.
[20] D. Higgs,et al. Acute splenic sequestration in homozygous sickle cell disease: natural history and management. , 1985, The Journal of pediatrics.
[21] J. Hanley,et al. The meaning and use of the area under a receiver operating characteristic (ROC) curve. , 1982, Radiology.
[22] G. Serjeant,et al. The Development of Haematological Changes in Homozygous Sickle Cell Disease: a Cohort Study from Birth to 6 Years , 1981, British journal of haematology.
[23] H. Pearson,et al. Physiologic anemia of the newborn infant. , 1971, The Journal of pediatrics.
[24] R. P. Spencer,et al. Functional asplenia in sickle-cell anemia. , 1969, The New England journal of medicine.
[25] D J Weatherall,et al. Inherited haemoglobin disorders: an increasing global health problem. , 2001, Bulletin of the World Health Organization.
[26] W. Rosse,et al. The cooperative study of sickle cell disease: review of study design and objectives. , 1982, The American journal of pediatric hematology/oncology.